Literature DB >> 25684945

Overexpression of B7-H3 augments anti-apoptosis of colorectal cancer cells by Jak2-STAT3.

Ting Zhang1, Bo Jiang1, Shi-Tao Zou1, Fen Liu1, Dong Hua1.   

Abstract

AIM: To investigate the role of the overexpression of B7-H3 in apoptosis in colorectal cancer cell lines and the underlying molecular mechanisms.
METHODS: SW620 cells that highly overexpressed B7-H3 (SW620-B7-H3-EGFP) and HCT8 cells stably transfected with B7-H3 shRNA (HCT8-shB7-H3) were previously constructed in our laboratory. Cells transfected with pIRES2-EGFP were used as negative controls (SW620-NC and HCT8-NC). Real-time PCR and western blotting analysis were used to detect the mRNA and protein expressions of the apoptosis regulator proteins Bcl-2, Bcl-xl and Bax. A cell proliferation assay was used to evaluate the survival rate and drug sensitivity of the cells. The effect of drug resistance was detected by a cell cycle assay. Active caspase-3 western blotting was used to reflect the anti-apoptotic ability of cells. Western blotting was also performed to determine the expression of proteins associated with the Jak2-STAT3 signaling pathway and the apoptosis regulator proteins after the treatment with AG490, a Jak2 specific inhibitor, in B7-H3 overexpressing cells. The data were analyzed by GraphPad Prism 6 using a non-paired t-test.
RESULTS: Whether by overexpression in SW620 cells or downregulation in HCT8, B7-H3 significantly affected the expression of anti- and pro-apoptotic proteins, at both the transcriptional and translational levels, compared with the negative control (P < 0.05). A cell proliferation assay revealed that B7-H3 overexpression increased the drug resistance of cells and resulted in a higher survival rate (P < 0.05). In addition, the results of cell cycle and active caspase-3 western blotting proved that B7-H3 overexpression inhibited apoptosis in colorectal cancer cell lines (P < 0.05). B7-H3 overexpression improved Jak2 and STAT3 phosphorylation and, in turn, increased the expression of the downstream anti-apoptotic proteins B-cell CLL/lymphoma 2 (Bcl-2) and Bcl-xl, based on western blotting (P < 0.05). After treating B7-H3 overexpressing cells with the Jak2-specific inhibitor AG490, the phosphorylation of Jak2 and STAT3, and the expression of Bcl-2 and Bcl-xl, decreased accordingly (P < 0.05). This finding suggested that the Jak2-STAT3 pathway is involved in the mechanism mediating the anti-apoptotic ability of B7-H3.
CONCLUSION: The overexpression of B7-H3 induces resistance to apoptosis in colorectal cancer cell lines by upregulating the Jak2-STAT3 signaling pathway, potentially providing new approaches to the treatment of colorectal cancer.

Entities:  

Keywords:  Apoptosis; B-cell CLL/lymphoma 2; B7-H3; Colorectal cancer; Jak2-STAT3; Overexpression; Signaling pathway

Mesh:

Substances:

Year:  2015        PMID: 25684945      PMCID: PMC4323456          DOI: 10.3748/wjg.v21.i6.1804

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  36 in total

1.  Adenoviral B7-H3 therapy induces tumor specific immune responses and reduces secondary metastasis in a murine model of colon cancer.

Authors:  Catalin M Lupu; Christoph Eisenbach; Alaviana D Lupu; Michael A Kuefner; Birgit Hoyler; Wolfgang Stremmel; Jens Encke
Journal:  Oncol Rep       Date:  2007-09       Impact factor: 3.906

Review 2.  Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy.

Authors:  Peter E Czabotar; Guillaume Lessene; Andreas Strasser; Jerry M Adams
Journal:  Nat Rev Mol Cell Biol       Date:  2014-01       Impact factor: 94.444

3.  B7-H3 expression in colorectal cancer: nuclear localization strongly predicts poor outcome in colon cancer.

Authors:  Vibeke Anett Ingebrigtsen; Kjetil Boye; Christina Tekle; Jahn Martin Nesland; Kjersti Flatmark; Oystein Fodstad
Journal:  Int J Cancer       Date:  2012-04-24       Impact factor: 7.396

Review 4.  Functions of the C-terminal domains of apoptosis-related proteins of the Bcl-2 family.

Authors:  Juan C Gómez-Fernández
Journal:  Chem Phys Lipids       Date:  2014-06-02       Impact factor: 3.329

5.  Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma.

Authors:  Jing Sun; Lu-jun Chen; Guang-bo Zhang; Jing-ting Jiang; Ming Zhu; Yan Tan; Hai-tao Wang; Bin-feng Lu; Xue-guang Zhang
Journal:  Cancer Immunol Immunother       Date:  2010-03-24       Impact factor: 6.968

6.  Swertiamarin attenuates inflammation mediators via modulating NF-κB/I κB and JAK2/STAT3 transcription factors in adjuvant induced arthritis.

Authors:  S Saravanan; V I Hairul Islam; N Prakash Babu; P Pandikumar; K Thirugnanasambantham; M Chellappandian; C Simon Durai Raj; M Gabriel Paulraj; S Ignacimuthu
Journal:  Eur J Pharm Sci       Date:  2014-02-25       Impact factor: 4.384

Review 7.  The B7 family and cancer therapy: costimulation and coinhibition.

Authors:  Xingxing Zang; James P Allison
Journal:  Clin Cancer Res       Date:  2007-09-15       Impact factor: 12.531

Review 8.  Signalling pathways mediating inflammatory responses in brain ischaemia.

Authors:  A M Planas; R Gorina; A Chamorro
Journal:  Biochem Soc Trans       Date:  2006-12       Impact factor: 5.407

9.  Silencing of B7-H3 increases gemcitabine sensitivity by promoting apoptosis in pancreatic carcinoma.

Authors:  Xin Zhao; Guang-Bo Zhang; Wen-Juan Gan; Feng Xiong; Zhi Li; Hua Zhao; Dong-Ming Zhu; Bin Zhang; Xue-Guang Zhang; DE-Chun Li
Journal:  Oncol Lett       Date:  2013-01-08       Impact factor: 2.967

10.  Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth.

Authors:  V De Simone; E Franzè; G Ronchetti; A Colantoni; M C Fantini; D Di Fusco; G S Sica; P Sileri; T T MacDonald; F Pallone; G Monteleone; C Stolfi
Journal:  Oncogene       Date:  2014-09-01       Impact factor: 9.867

View more
  32 in total

1.  Bisindolylmaleimide alkaloid BMA-155Cl induces autophagy and apoptosis in human hepatocarcinoma HepG-2 cells through the NF-κB p65 pathway.

Authors:  Xiao Sun; Lin Li; Hong-Guang Ma; Pu Sun; Qi-Lin Wang; Ting-Ting Zhang; Yue-Mao Shen; Wei-Ming Zhu; Xia Li
Journal:  Acta Pharmacol Sin       Date:  2017-03-06       Impact factor: 6.150

2.  B7-H3 promotes multiple myeloma cell survival and proliferation by ROS-dependent activation of Src/STAT3 and c-Cbl-mediated degradation of SOCS3.

Authors:  Liang Lin; Li Cao; Yang Liu; Ke Wang; Xinwei Zhang; Xiaodan Qin; Dandan Zhao; Jie Hao; Yingjun Chang; Xiaojun Huang; Bei Liu; Jun Zhang; Jin Lu; Qing Ge
Journal:  Leukemia       Date:  2018-12-20       Impact factor: 11.528

3.  B7-H3 increases thymidylate synthase expression via the PI3k-Akt pathway.

Authors:  Bo Jiang; Fen Liu; ZhiHui Liu; Ting Zhang; Dong Hua
Journal:  Tumour Biol       Date:  2016-01-20

4.  B7-H3 regulates migration and invasion in salivary gland adenoid cystic carcinoma via the JAK2/STAT3 signaling pathway.

Authors:  Teng-Fei Fan; Wei-Wei Deng; Lin-Lin Bu; Tian-Fu Wu; Wen-Feng Zhang; Zhi-Jun Sun
Journal:  Am J Transl Res       Date:  2017-03-15       Impact factor: 4.060

5.  Immunoregulatory Protein B7-H3 Reprograms Glucose Metabolism in Cancer Cells by ROS-Mediated Stabilization of HIF1α.

Authors:  Sangbin Lim; Hao Liu; Luciana Madeira da Silva; Ritu Arora; Zixing Liu; Joshua B Phillips; David C Schmitt; Tung Vu; Steven McClellan; Yifeng Lin; Wensheng Lin; Gary A Piazza; Oystein Fodstad; Ming Tan
Journal:  Cancer Res       Date:  2016-04-05       Impact factor: 12.701

6.  Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy.

Authors:  Elodie Picarda; Kim C Ohaegbulam; Xingxing Zang
Journal:  Clin Cancer Res       Date:  2016-05-20       Impact factor: 12.531

7.  B7-H3, Negatively Regulated by miR-128, Promotes Colorectal Cancer Cell Proliferation and Migration.

Authors:  Xiaomao Hu; Minxian Xu; Yangzhi Hu; Na Li; Lei Zhou
Journal:  Cell Biochem Biophys       Date:  2021-03-20       Impact factor: 2.194

8.  B7-H3 targeted antibody-based immunotherapy of malignant diseases.

Authors:  Theodoros Michelakos; Filippos Kontos; Omar Barakat; Luke Maggs; Joseph H Schwab; Cristina R Ferrone; Soldano Ferrone
Journal:  Expert Opin Biol Ther       Date:  2020-12-21       Impact factor: 4.388

Review 9.  Advances in immunotherapeutic targets for childhood cancers: A focus on glypican-2 and B7-H3.

Authors:  Nan Li; Madeline R Spetz; Dan Li; Mitchell Ho
Journal:  Pharmacol Ther       Date:  2021-05-14       Impact factor: 13.400

Review 10.  B7-H3: An Attractive Target for Antibody-based Immunotherapy.

Authors:  Filippos Kontos; Theodoros Michelakos; Tomohiro Kurokawa; Ananthan Sadagopan; Joseph H Schwab; Cristina R Ferrone; Soldano Ferrone
Journal:  Clin Cancer Res       Date:  2020-10-13       Impact factor: 13.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.